Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2017
Source ID
10.1016/j.nicl.2017.08.014

Entities

People

  • Andrew D Simmons
  • Daniel Ferreira
  • Eric Westman
  • Farshad Falahati
  • J-sebastian Muehlboeck
  • Lars-olof Wahlund
  • Maria Eriksdotter

Organizations

  • AbbVie
  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • BioClinica
  • Biogen
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eli Lilly and Company
  • GE HealthCare
  • Hoffmann-La Roche
  • Innogenetics
  • Johnson & Johnson Pharmaceutical Research and Development
  • Karolinska Institutet
  • Laboratoires Servier
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • Norman Cousins Center for Psychoneuroimmunology
  • Pfizer
  • Roche (United States)
  • Swedish Foundation for Strategic Research
  • Swedish Research Council
  • Takeda Pharmaceutical Company
  • United States Department of Defense
  • Åke Wibergs Stiftelse